Design
Review
Authors
Loading...
Diversity in cell-specific thrombin receptor trafficking may limit uniform antagonist efficacy; leaves open targeted mechanistic studies before clinical translation.
Key points are not available for this paper at this time.
Brass et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: